-
Medical journals
- Career
Sequencing of long non-coding RNAs in exosomes of colorectal cancer patients
Authors: M. Madrzyk 1,2; T. Macháčková 1; K. Trachtová 1; T. Catela Ivković 1; K. Součková 1; J. Kotouček 3; J. Mašek 3; T. Loja 1; M. Šachlová 4; O. Slabý 1
Authors‘ workplace: CEITEC – Středoevropský technologický institut, MU Brno 1; LF MU Brno 2; Výzkumný ústav veterinárního lékařství, v. v. i., Brno 3; Gastroenterologické oddělení, MOÚ Brno 4
Published in: Klin Onkol 2022; 35(Supplementum 1): 138-141
Category: Article
Overview
Background: The prognosis of patients with colorectal cancer (CRC) depends mainly on the extent of the disease at the time of diagnosis; therefore, early detection is one of the main prerequisites for successful treatment. Current research shows that exosomal long non-coding RNAs (lncRNAs) are associated with cancer development. As lncRNAs are often tissue specific, their quantification in exosomes is proposed as a non-invasive method for early detection of CRC. In this study, we aimed to optimize a protocol for analyzing exosomal lncRNAs from blood serum of CRC patients as potential diagnostic biomarkers. Material and methods: Exosomes were isolated by gel chromatography from 150 μl of serum of CRC patients and healthy donors. Their quality and quantity were confirmed by electron microscopy and dynamic light scattering (DLS) analysis; protein markers were detected by Western blot. After RNA isolation, cDNA libraries were prepared and sequenced using NextSeq 550. Results: We successfully isolated exosomes and verified them by several methods. Libraries were prepared from all samples despite very low volume of starting material. The sequencing data confirmed the presence of both protein-coding (50%) and non-coding RNAs, which consisted mainly of lncRNAs (28.2%), pseudogenes (15.2%) and other RNA types (6.5%). The results also showed significantly altered levels of some lncRNAs that could distinguish samples from CRC patients and healthy controls. Using gene set enrichment analysis (GSEA), we observed significantly enriched classes of genes related to DNA repair or cell cycle regulation. Conclusion: Our preliminary data suggest that lncRNAs represent a significant fraction of the RNA present in exosomes and that their distinct levels can separate CRC patients from healthy controls. The analysis of enriched genes also showed a significant representation of lncRNAs involved in cell cycle regulation and DNA repair, suggesting their possible involvement in cancerogenesis. However, the results need to be verified in a larger cohort of patients.
Keywords:
gene expression profiling – colorectal neoplasms – Exosomes – RNA, long noncoding – biomarkers, tumor
Sources
1. Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(3): 209–249. doi: 10.3322/ caac.21660.
2. Yáñez-Mó M, Siljander PRM, Andreu Z et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015; 4(2015): 1–60. doi: 10.3402/ jev.v4.27066.
3. Whiteside TL. Tumor-derived exosomes and their role in cancer progression. Adv Clin Chem 2016; 74(3): 103–141. doi: 10.1016/ bs.acc.2015.12.005.
4. Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics, Proteomics Bioinforma 2016; 14(1): 42–54. doi: 10.1016/ j.gpb.2015.09.006.
5. Yang Y, Yan X, Li X et al. Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications. Cancer Lett 2021; 504(2): 67–80. doi: 10.1016/ j.canlet.2021.01.009.
6. Liu T, Zhang X, Gao S et al. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget 2016; 7(51): 85551-85563. doi: 10.18632/ oncotarget.13465.
7. Derrien T, Johnson R, Bussotti G et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012; 22(9): 1775–1789. doi: 10.1101/ gr.132159.111.
8. Piao H-Y, Guo S, Wang Y et al. Long noncoding RNA NALT1-induced gastric cancer invasion and metastasis via NOTCH signaling pathway. World J Gastroenterol 2019; 25(44): 6508-6526. doi: 10.3748/ wjg.v25.i44.6508.
Labels
Paediatric clinical oncology Surgery Clinical oncology
Article was published inClinical Oncology
2022 Issue Supplementum 1-
All articles in this issue
- Editorial
- I. Onkologická prevence a screening
- II. Organizace a financování zdravotní péče
- III. Epidemiologie nádorů, klinické registry, zdravotnická informatika
- IV. Follow-up, sledování onkologických pacientů
- V. Vzdělávání, kvalita a bezpečnost v onkologické praxi
- VI. Diagnostické metody v onkologii a biobanking
- VII. Onkochirurgie, rekonstrukční chirurgie
- VIII. Radioterapeutické metody a radiofarmaka
- IX. Systémová protinádorová léčba
- X. Precizní medicína a personalizovaný přístup v onkologii
- XI. Imunoonkologie
- XII. Nežádoucí účinky protinádorové léčby a podpůrná léčba
- XIII. Paliativní péče a symptomatická léčba
- XIV. Nutriční podpora v onkologii
- XV. Ošetřovatelská péče a rehabilitace
- XVI. Psychosociální péče
- XVII. Hereditární nádorové syndromy
- XVIII. Nádory prsu
- XIX. Nádory kůže a maligní melanom
- XX. Nádory jícnu a žaludku
- XXI. Nádory tlustého střeva a konečníku
- XXII. Nádory slinivky, jater a žlučových cest
- XXIII. Nádory skeletu a sarkomy
- XXIV. Nádory hlavy a krku
- XXV. Nádory hrudníku, plic, průdušek a pleury
- XXVI. Gynekologická onkologie
- XXVII. Uroonkologie
- XXVIII. Neuroendokrinní a endokrinní nádory
- XXIX. Nádory nervového systému
- XXX. Hematoonkologie
- XXXI. Nádory dětí, adolescentů a mladých dospělých
- XXXII. Vývoj nových léčiv, farmakoekonomika, klinická farmacie v onkologii
- XXXIII. Základní, aplikovaný a klinický výzkum v onkologii
- XXXIV. Biologie nádorů
- XXXV. Integrativní přístupy v onkologii
- XXXVI. Umělá inteligence v onkologii
- XXXVII. Covid-19
- XXXVIII. Varia (ostatní, jinde nezařazené příspěvky)
- MicroRNAs as potential prognostic and predictive biomarkers in patients with atypical meningioma
- Pilot analysis of the PD-L1 expression in ovarian cancer patients treated with platinum-based chemotherapy
- Sequencing of long non-coding RNAs in exosomes of colorectal cancer patients
- Targeted RNA sequencing-based fusion gene analysis as a tool for diagnostics and therapeutic planning in pediatric cancer patients with solid tumors
- Sequencing of microRNAs in brain metastases as a new diagnostic tool
- Retrospective study of patients with tubo-ovarian cancers (n = 510) and an analysis of main factors influencing PFS and OS – the experience of a comprehensive oncology center during 2010–2019
- Clinical Oncology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- VIII. Radioterapeutické metody a radiofarmaka
- IV. Follow-up, sledování onkologických pacientů
- XXVIII. Neuroendokrinní a endokrinní nádory
- XXXVI. Umělá inteligence v onkologii
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career